Prevention of stroke and systemic embolism in atrial fibrillation (NICE TA249)
NICE TA249 - Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation
Where a DOAC is considered to be the most appropriate anticoagulant, edoxaban is to be used 1st line for patients with non-valvular AF unless there is a specific clinical reason not to do so.
Reason for decision:
Suitable for initiation in primary care